Sergeeva S, Loshchenova P, Oshchepkov D, Orishchenko K
Int J Mol Sci. 2024; 25(19).
PMID: 39408734
PMC: 11476898.
DOI: 10.3390/ijms251910405.
Kolesnichenko M, Scheidereit C
Signal Transduct Target Ther. 2024; 9(1):179.
PMID: 39069543
PMC: 11284200.
DOI: 10.1038/s41392-024-01893-2.
Bohi F, Hottiger M
Biomedicines. 2024; 12(7).
PMID: 39062190
PMC: 11275100.
DOI: 10.3390/biomedicines12071617.
Glynn R, Hayer K, Bassing C
J Immunol. 2024; 213(5):628-640.
PMID: 39007641
PMC: 11348802.
DOI: 10.4049/jimmunol.2300139.
Konrath F, Willenbrock M, Busse D, Scheidereit C, Wolf J
iScience. 2023; 26(10):107917.
PMID: 37817938
PMC: 10561052.
DOI: 10.1016/j.isci.2023.107917.
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer.
Moutafi M, Koliou G, Papaxoinis G, Economopoulou P, Kotsantis I, Gkotzamanidou M
Cancer Res Commun. 2023; 3(8):1514-1523.
PMID: 37575280
PMC: 10414130.
DOI: 10.1158/2767-9764.CRC-23-0051.
Crosstalk between cGAS-STING pathway and autophagy in cancer immunity.
Lu Q, Chen Y, Li J, Zhu F, Zheng Z
Front Immunol. 2023; 14:1139595.
PMID: 36936940
PMC: 10014609.
DOI: 10.3389/fimmu.2023.1139595.
The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivo.
Han C, McNamara B, Bellone S, Harold J, Manara P, Hartwich T
Gynecol Oncol. 2023; 170:172-178.
PMID: 36706643
PMC: 10023457.
DOI: 10.1016/j.ygyno.2023.01.015.
Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system.
Bound N, Vandenberg C, Kartikasari A, Plebanski M, Scott C
Front Genet. 2022; 13:886170.
PMID: 36159999
PMC: 9505691.
DOI: 10.3389/fgene.2022.886170.
TSG101 associates with PARP1 and is essential for PARylation and DNA damage-induced NF-κB activation.
Tufan A, Lazarow K, Kolesnichenko M, Sporbert A, von Kries J, Scheidereit C
EMBO J. 2022; 41(21):e110372.
PMID: 36124865
PMC: 9627669.
DOI: 10.15252/embj.2021110372.
Association between the genetic variants of base excision repair pathway genes and allergic rhinitis susceptibility in Chinese children.
Liu W, Zeng Q, Zeng Y, Tang Y, Luo R
World Allergy Organ J. 2022; 15(5):100650.
PMID: 35600838
PMC: 9096143.
DOI: 10.1016/j.waojou.2022.100650.
Non-enzymatic function of WRN RECQL helicase regulates removal of topoisomerase-I-DNA covalent complexes and triggers NF-κB signaling in cancer.
Gupta P, Majumdar A, Patro B
Aging Cell. 2022; 21(6):e13625.
PMID: 35582959
PMC: 9197415.
DOI: 10.1111/acel.13625.
Persistent DNA damage associated with ATM kinase deficiency promotes microglial dysfunction.
Bourseguin J, Cheng W, Talbot E, Hardy L, Lai J, Jeffries A
Nucleic Acids Res. 2022; 50(5):2700-2718.
PMID: 35212385
PMC: 8934660.
DOI: 10.1093/nar/gkac104.
PARP-1 inhibitors enhance the chemosensitivity of leukemia cells by attenuating NF-кB pathway activity and DNA damage response induced by Idarubicin.
Ke B, Li A, Fu H, Kong C, Liu T, Zhu Q
Acta Biochim Biophys Sin (Shanghai). 2022; 54(1):91-98.
PMID: 35130631
PMC: 9909352.
DOI: 10.3724/abbs.2021011.
Radiation-induced neuroinflammation: a potential protective role for poly(ADP-ribose) polymerase inhibitors?.
Gutierrez-Quintana R, Walker D, Williams K, Forster D, Chalmers A
Neurooncol Adv. 2022; 4(1):vdab190.
PMID: 35118383
PMC: 8807076.
DOI: 10.1093/noajnl/vdab190.
Nemo-Dependent, ATM-Mediated Signals from RAG DNA Breaks at Feedback Inhibit Recombination to Enforce Igκ Allelic Exclusion.
Glynn R, Bassing C
J Immunol. 2021; 208(2):371-383.
PMID: 34965965
PMC: 8756740.
DOI: 10.4049/jimmunol.2100696.
Therapeutic Potentials of Poly (ADP-Ribose) Polymerase 1 (PARP1) Inhibition in Multiple Sclerosis and Animal Models: Concept Revisiting.
Wang Y, Pleasure D, Deng W, Guo F
Adv Sci (Weinh). 2021; 9(5):e2102853.
PMID: 34935305
PMC: 8844485.
DOI: 10.1002/advs.202102853.
Interplay between ADP-ribosyltransferases and essential cell signaling pathways controls cellular responses.
Boehi F, Manetsch P, Hottiger M
Cell Discov. 2021; 7(1):104.
PMID: 34725336
PMC: 8560908.
DOI: 10.1038/s41421-021-00323-9.
Coordinated regulation of plant immunity by poly(ADP-ribosyl)ation and K63-linked ubiquitination.
Yao D, Arguez M, He P, Bent A, Song J
Mol Plant. 2021; 14(12):2088-2103.
PMID: 34418551
PMC: 9070964.
DOI: 10.1016/j.molp.2021.08.013.
Targeting the DNA damage response in immuno-oncology: developments and opportunities.
Chabanon R, Rouanne M, Lord C, Soria J, Pasero P, Postel-Vinay S
Nat Rev Cancer. 2021; 21(11):701-717.
PMID: 34376827
DOI: 10.1038/s41568-021-00386-6.